Results 271 to 280 of about 178,854 (310)

Nucleoside reverse transcriptase inhibitors/nucleotide reverse transcriptase inhibitors

Reactions Weekly, 2019
openaire   +1 more source

Use of nonnucleoside reverse-transcriptase inhibitors

American Journal of Health-System Pharmacy, 1998
C D, Holtzer, R L, Coleman
openaire   +2 more sources

Specific HIV-1 Reverse Transcriptase Inhibitors

Journal of Enzyme Inhibition, 1992
Z, Debyser, R, Pauwels, K, Andries, E, De Clercq   +3 more
openaire   +2 more sources

The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial

Nature Medicine, 2021
Barry A Borlaug, Dalane W Kitzman, Sanjiv J Shah   +2 more
exaly  

Nucleoside reverse transcriptase inhibitors

Reactions Weekly, 1998
openaire   +1 more source

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea

Ca-A Cancer Journal for Clinicians, 2018
Clement Chung
exaly  

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

Nature, 2020
Ugur Sahin, Petra Oehm, Mathias Vormehr
exaly  

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

Nucleotide reverse transcriptase inhibitors

Reactions Weekly, 2015
openaire   +1 more source